The implementation of new methods for optical illustration of structures, functions and diseases in tissues has revolutionized biomedical research. By using optically molecular imaging technologies, different molecules which are inside or outside a cell can selectively be shown by using contrast agents. This enables the illustration of invisibly physiological and pathological processes. These developments require optical methods which enable the accurate scanning and demonstration – not only in microscopic scale for laboratories, but also for clinical use. The aim is to show these information in an organ, system or the whole body and to offer applications provided which range from biotechnology to pharmaceutics and medicine.
The biomedical optic group develops new imaging and measuring technology for customers and advises them in developing new own products. One of the main working fields is the development of optical multispectral measuring and imaging technologies (Fraunhofer Attract Program). We evaluate measuring and imaging technologies – matched with the necessary biological samples - in cooperation with our clinical partners.
Our key technologies: